Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079916887> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2079916887 endingPage "1755" @default.
- W2079916887 startingPage "1749" @default.
- W2079916887 abstract "1. Glutamine analogues L-[alpha S,5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin) and 6-diazo-5-oxo-L-norleucine (DON) have been shown to possess cytotoxic activity against a wide variety of animal and human xenografted solid tumours, however their potential in man has been limited by toxicity. 2. We have analysed the effects of acivicin and DON on glutamine utilization to determine whether the reason for the disappointing therapeutic profile is solely due to the inefficient inhibition of glutamine metabolism. 3. Human myeloid leukaemic cells treated with acivicin inhibited ribonucleotide biosynthesis but not energy production via glutaminolysis and had little effect on viability, whereas treatment with DON inhibited both ribonucleotide biosynthesis and glutamine oxidation and resulted in reduced viability. 4. Treatment of the myeloid leukaemic cells with the glucose analogue 2-deoxy-D-glucose in addition to DON potentiated the inhibition of de novo nucleotide biosynthesis, glutaminolysis and glycolysis, and caused a further reduction in cell viability. 5. These results provide further support for the essential role of glutamine in cellular metabolism, and indicate that use of the glutamine analogue DON in the treatment of acute myeloid leukaemia may be more clinically effective if used in combination with 2-deoxy-D-glucose." @default.
- W2079916887 created "2016-06-24" @default.
- W2079916887 creator A5032502860 @default.
- W2079916887 creator A5043812839 @default.
- W2079916887 creator A5051209159 @default.
- W2079916887 creator A5053083760 @default.
- W2079916887 creator A5090158822 @default.
- W2079916887 date "1993-01-01" @default.
- W2079916887 modified "2023-10-14" @default.
- W2079916887 title "The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia In vitro" @default.
- W2079916887 cites W108528533 @default.
- W2079916887 cites W1658892750 @default.
- W2079916887 cites W1754310888 @default.
- W2079916887 cites W1989672017 @default.
- W2079916887 cites W1995449576 @default.
- W2079916887 cites W2005954302 @default.
- W2079916887 cites W2008699255 @default.
- W2079916887 cites W2027412912 @default.
- W2079916887 cites W2031848854 @default.
- W2079916887 cites W2036930304 @default.
- W2079916887 cites W2065333824 @default.
- W2079916887 cites W2084608057 @default.
- W2079916887 cites W2118912947 @default.
- W2079916887 cites W2318807168 @default.
- W2079916887 cites W2337180764 @default.
- W2079916887 doi "https://doi.org/10.1016/0020-711x(88)90303-5" @default.
- W2079916887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8138012" @default.
- W2079916887 hasPublicationYear "1993" @default.
- W2079916887 type Work @default.
- W2079916887 sameAs 2079916887 @default.
- W2079916887 citedByCount "29" @default.
- W2079916887 countsByYear W20799168872013 @default.
- W2079916887 countsByYear W20799168872015 @default.
- W2079916887 countsByYear W20799168872016 @default.
- W2079916887 countsByYear W20799168872017 @default.
- W2079916887 countsByYear W20799168872019 @default.
- W2079916887 countsByYear W20799168872020 @default.
- W2079916887 countsByYear W20799168872021 @default.
- W2079916887 countsByYear W20799168872022 @default.
- W2079916887 crossrefType "journal-article" @default.
- W2079916887 hasAuthorship W2079916887A5032502860 @default.
- W2079916887 hasAuthorship W2079916887A5043812839 @default.
- W2079916887 hasAuthorship W2079916887A5051209159 @default.
- W2079916887 hasAuthorship W2079916887A5053083760 @default.
- W2079916887 hasAuthorship W2079916887A5090158822 @default.
- W2079916887 hasConcept C181199279 @default.
- W2079916887 hasConcept C185592680 @default.
- W2079916887 hasConcept C20251656 @default.
- W2079916887 hasConcept C2776309477 @default.
- W2079916887 hasConcept C2778160063 @default.
- W2079916887 hasConcept C2779349466 @default.
- W2079916887 hasConcept C515207424 @default.
- W2079916887 hasConcept C553450214 @default.
- W2079916887 hasConcept C55493867 @default.
- W2079916887 hasConcept C62231903 @default.
- W2079916887 hasConcept C86803240 @default.
- W2079916887 hasConceptScore W2079916887C181199279 @default.
- W2079916887 hasConceptScore W2079916887C185592680 @default.
- W2079916887 hasConceptScore W2079916887C20251656 @default.
- W2079916887 hasConceptScore W2079916887C2776309477 @default.
- W2079916887 hasConceptScore W2079916887C2778160063 @default.
- W2079916887 hasConceptScore W2079916887C2779349466 @default.
- W2079916887 hasConceptScore W2079916887C515207424 @default.
- W2079916887 hasConceptScore W2079916887C553450214 @default.
- W2079916887 hasConceptScore W2079916887C55493867 @default.
- W2079916887 hasConceptScore W2079916887C62231903 @default.
- W2079916887 hasConceptScore W2079916887C86803240 @default.
- W2079916887 hasIssue "12" @default.
- W2079916887 hasLocation W20799168871 @default.
- W2079916887 hasLocation W20799168872 @default.
- W2079916887 hasOpenAccess W2079916887 @default.
- W2079916887 hasPrimaryLocation W20799168871 @default.
- W2079916887 hasRelatedWork W1996365670 @default.
- W2079916887 hasRelatedWork W2028115664 @default.
- W2079916887 hasRelatedWork W2038307607 @default.
- W2079916887 hasRelatedWork W2040076847 @default.
- W2079916887 hasRelatedWork W2078561983 @default.
- W2079916887 hasRelatedWork W2132670294 @default.
- W2079916887 hasRelatedWork W2396685132 @default.
- W2079916887 hasRelatedWork W2440640758 @default.
- W2079916887 hasRelatedWork W4207027829 @default.
- W2079916887 hasRelatedWork W4239653358 @default.
- W2079916887 hasVolume "25" @default.
- W2079916887 isParatext "false" @default.
- W2079916887 isRetracted "false" @default.
- W2079916887 magId "2079916887" @default.
- W2079916887 workType "article" @default.